Open AccessEndobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO
Author(s) -
Marlies van Dijk,
Jorine E. Hartman,
Karin Klooster,
Nick H.T. ten Hacken,
Huib A.M. Kerstjens,
DirkJan Slebos
Publication year - 2020
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000505428
Subject(s) - dlco , medicine , lung volumes , gastroenterology , cardiology , lung , surgery , diffusing capacity , lung function
For selected patients with severe emphysema, bronchoscopic lung volume reduction with endobronchial valves (EBV) is recognized as an additional treatment option. In most trials investigating EBV treatment, patients with a very low diffusing capacity (DLCO) were excluded from participation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom